{
  "created_at": "Sun Jan 09 11:17:24 +0000 2022",
  "id_str": "1480082641290420232",
  "full_text": "New research has mapped differences between all major versions of SARS-CoV-2 and suggests that, although administering existing vaccines is still useful, Omicron is so different from other strains that they may need updating  https://t.co/FIWHi0aM8Q",
  "display_text_range": [
    0,
    249
  ],
  "entities": {
    "hashtags": [],
    "symbols": [],
    "user_mentions": [],
    "urls": [
      {
        "url": "https://t.co/FIWHi0aM8Q",
        "expanded_url": "https://econ.st/3fk9rYp",
        "display_url": "econ.st/3fk9rYp",
        "indices": [
          226,
          249
        ]
      }
    ]
  },
  "user": {
    "name": "The Economist",
    "screen_name": "TheEconomist",
    "profile_image_url_https": "https://pbs.twimg.com/profile_images/879361767914262528/HdRauDM-_normal.jpg"
  },
  "retweet_count": 36,
  "favorite_count": 80,
  "possibly_sensitive": false,
  "original_created_at": "Sun Jan 09 07:42:54 +0000 2022",
  "localize": [
    {
      "locale": "ja",
      "full_text": "新しい研究により、SARS-CoV-2の主要なバージョン間の差異が明らかになった。既存のワクチンの投与は依然として有効であるが、Omicronは他の株と大きく異なるため、ワクチンの更新が必要かもしれないことを示唆しているhttps://t.co/FIWHi0aM8Q。"
    },
    {
      "locale": "zh",
      "full_text": "新的研究绘制了SARS-CoV-2所有主要版本之间的差异，并表明，尽管注射现有的疫苗仍然有用，但Omicron与其他毒株的差异很大，可能需要更新https://t.co/FIWHi0aM8Q。"
    },
    {
      "locale": "zh-Hant",
      "full_text": "新的研究繪製了SARS-CoV-2所有主要版本之間的差異，並表明，儘管注射現有的疫苗仍然有用，但Omicron與其他毒株的差異很大，可能需要更新https://t.co/FIWHi0aM8Q。"
    }
  ]
}